197 related articles for article (PubMed ID: 37612044)
1. Saponin-based adjuvants enhance antigen cross-presentation in human CD11c
Ho NI; Huis In 't Veld LGM; van Eck van der Sluijs J; Heuts BMH; Looman MWG; Kers-Rebel ED; van den Dries K; Dolstra H; Martens JHA; Hobo W; Adema GJ
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37612044
[TBL] [Abstract][Full Text] [Related]
2. Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation.
Huis In 't Veld LGM; Ho NI; Wassink M; den Brok MH; Adema GJ
Cell Mol Life Sci; 2022 Apr; 79(5):231. PubMed ID: 35396971
[TBL] [Abstract][Full Text] [Related]
3. CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01.
Bosteels C; Fierens K; De Prijck S; Van Moorleghem J; Vanheerswynghels M; De Wolf C; Chalon A; Collignon C; Hammad H; Didierlaurent AM; Lambrecht BN
Front Immunol; 2020; 11():606805. PubMed ID: 33519816
[TBL] [Abstract][Full Text] [Related]
4. Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation.
den Brok MH; Büll C; Wassink M; de Graaf AM; Wagenaars JA; Minderman M; Thakur M; Amigorena S; Rijke EO; Schrier CC; Adema GJ
Nat Commun; 2016 Nov; 7():13324. PubMed ID: 27819292
[TBL] [Abstract][Full Text] [Related]
5. Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Ho NI; Huis In 't Veld LGM; Raaijmakers TK; Adema GJ
Front Immunol; 2018; 9():2874. PubMed ID: 30619259
[TBL] [Abstract][Full Text] [Related]
6. Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic state in cross-presenting dendritic cells.
Lee W; Kingstad-Bakke B; Paulson B; Larsen A; Overmyer K; Marinaik CB; Dulli K; Toy R; Vogel G; Mueller KP; Tweed K; Walsh AJ; Russell J; Saha K; Reyes L; Skala MC; Sauer JD; Shayakhmetov DM; Coon J; Roy K; Suresh M
PLoS Pathog; 2021 Jan; 17(1):e1009168. PubMed ID: 33444400
[TBL] [Abstract][Full Text] [Related]
7. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
8. Development of an Inflammatory CD14
Iwabuchi R; Ide K; Terahara K; Wagatsuma R; Iwaki R; Matsunaga H; Tsunetsugu-Yokota Y; Takeyama H; Takahashi Y
Front Immunol; 2021; 12():643040. PubMed ID: 33790912
[TBL] [Abstract][Full Text] [Related]
9. Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destruction.
den Brok MH; Nierkens S; Wagenaars JA; Ruers TJ; Schrier CC; Rijke EO; Adema GJ
Vaccine; 2012 Jan; 30(4):737-44. PubMed ID: 22138178
[TBL] [Abstract][Full Text] [Related]
10. Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes.
Raaijmakers TK; van den Bijgaart RJE; den Brok MH; Wassink M; de Graaf A; Wagenaars JA; Nierkens S; Ansems M; Scheffer GJ; Adema GJ
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461350
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With
Li Y; Mateu E
Front Immunol; 2021; 12():674185. PubMed ID: 34177915
[TBL] [Abstract][Full Text] [Related]
12. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
13. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.
Bachem A; Güttler S; Hartung E; Ebstein F; Schaefer M; Tannert A; Salama A; Movassaghi K; Opitz C; Mages HW; Henn V; Kloetzel PM; Gurka S; Kroczek RA
J Exp Med; 2010 Jun; 207(6):1273-81. PubMed ID: 20479115
[TBL] [Abstract][Full Text] [Related]
14. IL-10 promotes homeostatic proliferation of human CD8(+) memory T cells and, when produced by CD1c(+) DCs, shapes naive CD8(+) T-cell priming.
Nizzoli G; Larghi P; Paroni M; Crosti MC; Moro M; Neddermann P; Caprioli F; Pagani M; De Francesco R; Abrignani S; Geginat J
Eur J Immunol; 2016 Jul; 46(7):1622-32. PubMed ID: 27129615
[TBL] [Abstract][Full Text] [Related]
15. Vaccine adjuvants to engage the cross-presentation pathway.
Lee W; Suresh M
Front Immunol; 2022; 13():940047. PubMed ID: 35979365
[TBL] [Abstract][Full Text] [Related]
16. Lung cDC1 and cDC2 dendritic cells priming naive CD8
Si Y; Wang Y; Tian Q; Wang Q; Pollard JM; Srivastava PK; Esser-Kahn AP; Collier JH; Sperling AI; Chong AS
Cell Rep; 2023 Oct; 42(10):113299. PubMed ID: 37864794
[TBL] [Abstract][Full Text] [Related]
17. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
18. Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions.
Yin X; Yu H; Jin X; Li J; Guo H; Shi Q; Yin Z; Xu Y; Wang X; Liu R; Wang S; Zhang L
J Immunol; 2017 Feb; 198(4):1553-1564. PubMed ID: 28087664
[TBL] [Abstract][Full Text] [Related]
19. Cross-presentation of Exogenous Antigens.
Li B; Hu L
Transfus Clin Biol; 2019 Nov; 26(4):346-351. PubMed ID: 30797678
[TBL] [Abstract][Full Text] [Related]
20. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
Front Immunol; 2018; 9():2775. PubMed ID: 30542351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]